| Objective: To observe the effect of sufentanil combined withdexmedetomidine on Patient-controlled analgesia in children undergoingtonsillectomy.Methods: Eighty children with ASA physical status I or II undergoing elective tonsillectomy were randomly divided into four groups(S,SD1,SD2,SD3) with20each: group S received sufentanil0.04ug.kg-1.h-1, groupSD1received sufentanil0.03ug.kg-1.h-1+dexmedetomidine0.03ug.kg-1.h-1, groupSD2received sufentanil0.03ug.kg-1.h-1+dexmedetomidine0.04ug.kg-1.h-1, groupSD2received sufentanil0.03ug.kg-1.h-1+dexmedetomidine0.05ug.kg-1.h-1. ThePatient-Controlled Analgesia pump was set in all children as follow: a initial dose0ml,continuous perfusion rate2ml/h, single bolus2ml, lockout time15min, totalvolume100ml. Faces pain scale(FPS) and Ramsay sedation scale were recorded at30min,1h,2h,4h,12h,24h and48h postoperatively. The number ofpatient-controlled press of the pump and the incidence of side effects wererecorded.Results: FPS of the four groups unless group SD1at all the time points wereless than4. Compared with group S, group SD1had higher FPS scores at2h,4hpostoperatively (p<0.05),group SD2,SD3had lower FPS scores at4h,12hpostoperatively(p<0.05). Compared with group S, group SD3had higher Ramsayscores at2h,4h postoperatively(p<0.05).The number of self-controlled press of thepump in group SD1was markedly more than other groups (p<0.05). Theincidence of nausea and vomiting in group S was higher than groups SD2,SD3(p<0.05). Conclusion: Dexmedetomidine can reduce postoperative consumption ofsufentanil in Children undergoing tonsillectomy, decrease the incidence of nausea andvomiting and sustain an stable hemodynamics. The recommended dose ofdexmedetomidine is0.04ug.kg-1.h-1. |